Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients

Xin-Sen Xu,Wei Chen,Runchen Miao,Yanyan Zhou,Zhi-Xin Wang,Ling-Qiang Zhang,Kai Qu,Qing Pang,Rui-Tao Wang,Chang Liu
DOI: https://doi.org/10.4103/0366-6999.159356
IF: 6.133
2015-01-01
Chinese Medical Journal
Abstract:Background: To compare the clinicopathological features and prognosis between younger and aged patients with hepatocellular carcinoma (HCC). Methods: We analyzed the outcome of 451 HCC patients underwent liver resection, transcatheter arterial chemoembolization and radiofrequency ablation, respectively. Then risk factors for aged and younger patients' survival were evaluated by multivariate analysis, respectively. Results: The patients who were older than 55 years old were defined as the older group. The overall survival for aged patients was significantly worse than those younger patients. The younger patients had similar liver functional reserve but more aggressive tumor factors than aged patients. Cox regression analysis showed that the elevated levels of aspartate aminotransferase (AST) (Wald chi(2) = 3.963, P = 0.047, hazard ratio [HR] = 1.453, 95% confidence interval [CI]: 1.006-2.098), lower albumin (Wald chi(2) = 12.213, P < 0.001, HR = 1.982, 95% CI: 1.351-2.910), tumor size (Wald chi(2) = 8.179, P = 0.004, HR = 1.841, 95% CI: 1.212-2.797), and higher alpha-fetoprotein level (Wald chi(2) = 4.044, P = 0.044, HR = 1.465, 95% CI: 1.010-2.126) were independent prognostic factors for aged patients, while only elevated levels of AST (Wald chi(2) = 14.491, P < 0.001, HR = 2.285, 95% CI: 1.493-3.496) and tumor size (Wald chi(2) = 21.662, P < 0.001, HR = 2.928, 95% CI: 1.863-4.604) were independent prognostic factors for younger patients. Conclusions: Age is a risk factor to determine the prognosis of patients with HCC. Aged patients who have good liver functional reserve are still encouraged to receive curative therapy.
What problem does this paper attempt to address?